Post-COVID-19 Condition

Annu Rev Med. 2023 Jan 27:74:55-64. doi: 10.1146/annurev-med-043021-030635. Epub 2022 Aug 1.

Abstract

An estimated 10-15% of those infected with SARS-CoV-2 may have post-COVID-19 condition. Common lingering signs and symptoms include shortness of breath, fatigue, high heart rate, and memory and cognitive dysfunction even several months after infection, often impacting survivors' quality of life. The prevalence and duration of individual symptoms remain difficult to ascertain due to the lack of standardized research methods across various studies and limited patient follow-up in clinical studies. Nonetheless, data indicate post-COVID-19 condition may occur independent of acuity of initial infection, hospitalization status, age, or pre-existing comorbidities. Risk factors may include female sex and underlying respiratory or psychiatric disease. Supportive therapies to mitigate symptoms remain the mainstay of treatment. Reassuringly, most patients experience a reduction in symptoms by 1 year. The use of a universal case definition and shared research methods will allow for further clarity regarding the pervasiveness of this entity and its long-term health consequences.

Keywords: SARS-CoV-2; long COVID; long-haul COVID; post-COVID-19 condition; postacute COVID-19 syndrome.

Publication types

  • Review
  • Research Support, N.I.H., Extramural
  • Research Support, Non-U.S. Gov't

MeSH terms

  • COVID-19*
  • Cognitive Dysfunction* / epidemiology
  • Cognitive Dysfunction* / etiology
  • Dyspnea
  • Female
  • Humans
  • Quality of Life
  • SARS-CoV-2